JAK1 selective inhibitors for the treatment of spondyloarthropathies
As our understanding of the pathogenesis of spondyloarthropathies improves, focus has turned to the role janus kinase (JAK) mediated signal transduction and inhibiting its actions as a therapeutic mechanism. Small molecule inhibitors of JAK exist, with variable selectivity for the different JAK isof...
| Main Authors: | , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
Oxford University Press
2021
|